Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Relationship Between Decreased Serum Klotho Protein and Cognitive Impairment in Patients After Abdominal Surgery.

Journal of inflammation research·2026
Same author

TumorSynth: Integrated Brain Tumor and Tissue Segmentation on Brain MRI Scans of Any Resolution and Contrast.

Radiology. Imaging cancer·2026
Same author

Aberrant bone marrow granulopoiesis generates neutrophils that promote B cell activity in neuromyelitis optica spectrum disorder.

Science translational medicine·2026
Same author

Normal-Appearing White Matter Injury Mediates Chronic Deep Venous Hypoxia and Disease Progression in Multiple Sclerosis.

Annals of clinical and translational neurology·2026
Same author

Spinal Cord Infarction Versus Idiopathic Transverse Myelitis: Clinical, Radiological, and Functional Insights From a Retrospective Cohort Study.

Annals of clinical and translational neurology·2026
Same author

The Effect of Adding Different Varieties of Osmanthus on the Antioxidant Activity and Flavor of Barley Beer.

Journal of food science·2026
Same journal

Preoperative breast MRI and long-term survival in ductal carcinoma in situ: a propensity score-weighted analysis.

European radiology·2026
Same journal

Efficacy evaluation of artificial intelligence in radiological imaging diagnosis based on randomized controlled trials: a scoping review.

European radiology·2026
Same journal

The bMRI-QUAL scoring system: an important first step toward standardizing breast MRI quality.

European radiology·2026
Same journal

Spectral CT-based habitat analysis for predicting pathologic response to neoadjuvant therapy in gastric cancer.

European radiology·2026
Same journal

MR-guided microwave ablation of liver tumors: outcomes in local tumor control and determinants of treatment success.

European radiology·2026
Same journal

AI integration in pediatric radiology: perspectives from international academic leaders.

European radiology·2026
See all related articles

Related Experiment Video

Updated: Jun 27, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.6K

Spatial structural abnormality maps associated with cognitive and physical performance in relapsing-remitting

Zhizheng Zhuo1, Ningnannan Zhang2, Feng Ao3,4

  • 1Department of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. 18612161210@163.com.

European Radiology
|October 29, 2024
PubMed
Summary
This summary is machine-generated.

Deep learning identified five relapsing-remitting multiple sclerosis (RRMS) subtypes based on brain abnormalities, revealing distinct cognitive and physical performance patterns. These spatial maps aid in understanding RRMS heterogeneity and personalized treatment strategies.

Keywords:
Brain abnormalityCognitionDeep learningDisabilityRelapsing-remitting multiple sclerosis

More Related Videos

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
09:33

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Published on: July 28, 2013

28.4K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.4K

Related Experiment Videos

Last Updated: Jun 27, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.6K
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
09:33

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Published on: July 28, 2013

28.4K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.4K

Area of Science:

  • Neuroscience
  • Artificial Intelligence
  • Medical Imaging

Background:

  • Relapsing-remitting multiple sclerosis (RRMS) presents significant heterogeneity in cognitive and physical performance.
  • Understanding the underlying brain abnormalities is crucial for effective patient management.

Purpose of the Study:

  • To characterize brain abnormalities associated with cognitive and physical performance in RRMS patients.
  • To utilize a deep learning algorithm for identifying distinct RRMS subtypes.

Main Methods:

  • A 3D nnU-Net deep learning model was used to generate spatial abnormality maps from T1-weighted MRI scans of 281 RRMS patients.
  • Patients were categorized into subtypes, and clinical/MRI features were compared using Kruskal-Wallis tests.
  • Kaplan-Meier analysis assessed disability progression, with validation on two additional datasets.

Main Results:

  • Five distinct RRMS subtypes were identified, each with unique cognitive and physical performance profiles and disability progression risks.
  • Subtypes varied in cognitive scores, physical disability severity, brain volume loss, and relapse rates.
  • Validation on external datasets confirmed the robustness of the identified subtypes.

Conclusions:

  • Spatial abnormality maps derived from deep learning can effectively explain the heterogeneity in RRMS.
  • These findings support the potential for stratified management and personalized treatment approaches in RRMS.